Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

被引：0

作者：

Demosthenes Makris

Arnaud Scherpereel

Marie Christine Copin

Guillaume Colin

Luc Brun

Jean Jacques Lafitte

Charles Hugo Marquette

机构：

[1] CHRU of Lille,Pulmonary and Thoracic Oncology Department

[2] INSERM Unit 774,Pathology Department

[3] Institut Pasteur of Lille,Clinique des Maladies Respiratoires

[4] CHRU of Lille,undefined

[5] Hôpital Albert Calmette,undefined

[6] CHRU de Lille,undefined

来源：

BMC Cancer | / 7卷

关键词：

Docetaxel; Gemcitabine; Human Epidermal Growth Factor Receptor; Erlotinib; Interstitial Lung Disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Interstitial lung disease: is interstitial lung disease the same as scleroderma lung disease? [J].

Murray, Lynne A. ;

Rubinowitz, Ami ;

Herzog, Erica L. .

CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (06) :656-662

[42] NESTED CASE CONTROL STUDY OF PROTEOMIC BIOMARKERS FOR INTERSTITIAL LUNG DISEASE IN JAPANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER TREATED WITH ERLOTINIB [J].

Katakami, Nobuyuki ;

Atagi, Shinji ;

Yoshioka, Hiroshige ;

Fukuoka, Masahiro ;

Ogiwara, Atsushi ;

Imai, Masato ;

Ueda, Masamichi ;

Matsui, Shigeyuki .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) :S458-S458

[43] Modern drug therapy for systemic sclerosis associated interstitial lung disease [J].

Aringer, Martin ;

Koschel, Dirk ;

Krause, Andreas ;

Schneider, Udo ;

Glaeser, Sven .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (04) :179-186

[44] Independent review of interstitial lung disease associated with death in TRIBUTE (Paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer [J].

Yoneda, Ken Y. ;

Shelton, David K. ;

Beckett, Laurel A. ;

Gandara, David R. .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) :537-543

[45] Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient [J].

Tsubata, Yukari ;

Hamada, Akinobu ;

Sutani, Akihisa ;

Isobe, Takeshi .

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (01) :154-156

[46] Erlotinib-associated alopecia in a lung cancer patient [J].

Costa, Daniel B. ;

Kobayashi, Susumu ;

Schumer, Susan T. .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (12) :1136-1138

[47] Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study [J].

Miura, Yukiko ;

Saito, Yoshinobu ;

Atsumi, Kenichiro ;

Takeuchi, Susumu ;

Miyanaga, Akihiko ;

Mizutani, Hideaki ;

Minegishi, Yuji ;

Noro, Rintaro ;

Seike, Masahiro ;

Shinobu, Kunugi ;

Kubota, Kaoru ;

Gemma, Akihiko .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (07) :674-680

[48] Fatal interstitial lung disease associated with a series of tyrosine kinase inhibitors treatment in a non-small cell lung cancer patient: a case report [J].

Han, Ting ;

Hu, Jiong ;

Shi, Yongheng ;

Wang, Liwei ;

Jiao, Feng .

TRANSLATIONAL CANCER RESEARCH, 2020, 9 (05) :3762-3765

[49] Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease [J].

Fisher, Dane A. ;

Murphy, Mark C. ;

Montesi, Sydney B. ;

Hariri, Lida P. ;

Hallowell, Robert W. ;

Keane, Florence K. ;

Lanuti, Michael ;

Mooradian, Meghan J. ;

Fintelmann, Florian J. .

RADIOLOGIC CLINICS OF NORTH AMERICA, 2022, 60 (06) :993-1002

[50] Interstitial lung disease in patients with small cell lung cancer [J].

Miyazaki, Kunihiko ;

Satoh, Hiroaki ;

Kurishima, Koichi ;

Nakamura, Ryota ;

Ishikawa, Hiroichi ;

Kagohashi, Katsunori ;

Hizawa, Nobuyuki .

MEDICAL ONCOLOGY, 2010, 27 (03) :763-767

← 1 2 3 4 5 →